Anti-Thrombotic Therapy - Update 2017

Watch the webcasts

Scientific programme

Course Directors: Raffaele De Caterina (IT), Erik L. Grove (DK), Steen D. Kristensen (DK), Marco Zimarino (IT)

Faculty: Jean-Philippe Collet (FR), Kurt Huber (AU), David J. Moliterno (USA), Joao Morais (PT), Franz-Josef Neumann (GE), Giuseppe Patti (IT), Bianca Rocca (IT), Helmut Schühlen (GE), Robert F. Storey (UK)

Thursday 23 February

12:30-14:00: Arrival at the European Heart House and Lunch

14:00-14:10: Welcome – R. De Caterina, S.D. Kristensen

SESSION 1: PATHOPHYSIOLOGY AND METHODOLOGY – Chairs: E. Grove and R. De Caterina

Understanding Thrombosis in...
14:10-14:25  Acute Coronary Syndromes – S.D. Kristensen
14:25-14:30  Discussion
14:30-14:45  Venous Thromboembolism – J. Morais
14:45-14:50  Discussion
14:50-15:05  Atrial fibrillation – R. De Caterina
15:05-15:10  Discussion
Methodology
15:10-15:20  Platelet function testing – B. Rocca
15:20-15:30  Evaluating Coagulation – E. Grove
15:30-15:45  Discussion

15:45-16:15  Coffee break    

SESSION 2:  ACS - ACUTE THERAPY (before the cath lab, in the cath lab, and when a cath lab is not available) – Chairs: M. Zimarino and S.D. Kristensen

16:15-16:30  ESC Guidelines: focus on oral antiplatelet therapy before and in the cath lab – S.D. Kristensen
16:30-16:40  Discussion
16:40-16:50  Pretreatment with oral P2Y12 inhibitors in NSTEMI and STEMI - against – J-P. Collet
16:50-17:00  Pretreatment with oral P2Y12 inhibitors in NSTEMI and STEMI - in favour – M. Zimarino
17:00-17:15  Discussion
17.15-17:40  Intravenous antithrombotic agents: bivalirudin, fondaparinux, LMWH, glycoprotein IIb/IIIa inhibitors, cangrelor - D.J. Moliterno
17:40-18:00  Discussion

20:00-22:00  Group Dinner

Friday 24 February

SESSION 3: ACS AFTER THE STORM - ORAL ANTIPLATELET AGENTS – Chairs: D.J. Moliterno and K. Huber

09:00-09:15  ESC Guidelines – drug therapy after the cath lab – J-P. Collet
09:15-09:20  Discussion
09:20-09:35  Duration of DAPT in ACS – R.F. Storey
09:35-09:40  Discussion
09:40-09:55  Thrombin receptor antagonists and other new oral antiplatelet drugs - D.J. Moliterno       
09:55-10:10  Discussion

10:10-10:30  Coffee break

SESSION 4: CORONARY INTERVENTIONS 2017 – Chairs: R. Storey and D.J. Moliterno

10:30-10:45  Thrombectomy – how? For whom? – M. Zimarino
10:45-10:50  Discussion
10:50-11:05  DES or maybe BMS – which one(s)? – H. Schühlen
11:05-11:10  Discussion
11:10-11:25  Bioresorbable stents – for all or for few? – F-J. Neumann
11:25-11:30  Discussion

SESSION 5: STABLE CAD – Chairs: S.D. Kristensen and K. Huber

11:30-11:40  Optimal medical therapy in patients with stable CAD – R.F. Storey
11:40-11:45  Discussion
11:45-11:55  FFR? FFR-CT? Ischaemia testing? – M. Zimarino
11:55-12:00  Discussion
12:00-12:10  Duration of DAPT in Stable CAD after PCI – H. Schühlen
12:10-12:15  Discussion

12:15-16:00  LUNCH AND EXTRAMURAL MEET-THE-EXPERTS SESSION

SESSION 6: NOACs BEYOND ATRIAL FIBRILLATION – Chairs: B. Rocca  and K. Huber

16:00-16:15  The pharmacology of NOACs (including antidotes) – B. Rocca
16:15-16:20  Discussion
16:20-16:35  NOACs in VTE - drug selection according to patient’s risk profile and duration of therapy – J. Morais
16:35-16:40  Discussion
16:40-16:55  NOACs in ACS – R. De Caterina
16:55-17:00  Discussion

17:00-17:15  Coffee break

SESSION 4: ATRIAL FIBRILLATION I – Chairs: J. Morais and B. Rocca

17:15-17:30  Warfarin or NOACs – Lessons from real-life data in different countries – G. Patti
17:30-17:35  Discussion
17:35-17:50  LAA occluders: for whom? – E. Grove
17:50-17:55  Discussion
17:55-18:10  Peri-cardioversion and peri-ablation anticoagulation – G. Patti
18:10-18:25  Discussion

Saturday 25 February

SESSION 8: DIFFICULT CLINICAL CASES – Chairs: M. Zimarino  and E. Grove
The best case will be awarded a prize

09:00-09:15  Case 1 presented by Giampaolo Niccoli
09:15-09:20  Discussion
09:20-09:35  Case 2 presented by Mark Thomas
09:35-09:40  Discussion
09:40-09:55  Case 3 presented by Allan Bohm
09:55-10:00  Discussion
10:00-10:15  Case 4 presented by Giampaolo Niccoli
10:15-10:20  Discussion
10:20-10:25  Voting for the best clinical case

10:25-10:50  Coffee break

SESSION 9: COEXISTING ATRIAL FIBRILLATION AND CAD – Chairs: R. De Caterina and S.D. Kristensen

10:50-11:05  Stable coronary artery disease, elective stenting and atrial fibrillation – K. Huber
11:05-11:10  Discussion
11:10-11:25  After an ACS – R. De Caterina
11:25-11:30  Discussion

11:30-11:40  Best Clinical Case Prize Winner Announcement – E. Grove and M. Zimarino

11:40-11:55  Closing remarks – Course Director

11:45    End of course

Webcasts